UPLC is a faster, higher-pressure form of HPLC. It uses columns packed with particles under 2 µm and runs at far higher pressures, so it separates more peaks in less time. Conventional HPLC uses larger particles at lower pressure. It is slower, but cheaper to run and still the workhorse of validated quality control. For peptides, the gap matters most when you need to see small impurities sitting close to the main peak.
This guide sets out the practical differences, what they cost, how to move a method from one platform to the other, and how to read a peptide purity figure once you know which technique produced it.
TL;DR
- HPLC typically runs at up to about 400 bar with 3–5 µm particles. UPLC/UHPLC runs at roughly 1,000 bar and above with sub-2 µm particles.
- UPLC is a Waters trademark. UHPLC is the vendor-neutral term for the same class of technology.
- For complex peptide samples, UPLC gives higher peak capacity and better resolution of closely eluting impurities. For routine QC of validated methods, HPLC remains rugged and economical.
- A purity percentage only means something alongside the method behind it: column, gradient, detection wavelength and system.
- When you buy research peptides, ask for the Certificate of Analysis and read the method, not just the headline figure.
Table of Contents
- What HPLC and UPLC have in common
- The core differences
- Why the difference matters for peptides
- What it costs to run each
- Which one should you use?
- Moving a method between HPLC and UPLC
- Reading a peptide purity figure
- Our perspective on HPLC, UPLC and purity
- Sourcing peptides for your analytical work
- FAQ
- Sources
What HPLC and UPLC have in common
Both are forms of liquid chromatography. A liquid mobile phase carries your sample through a packed column, and the components separate because they interact differently with the stationary phase. A detector, usually UV absorbance for peptides, records each component as a peak. Chromatography Today's overview makes the same point: it is easy to confuse the two because they share the same basic principle.
For peptides, the usual mode is reversed-phase: a C18 or similar column, a water and acetonitrile gradient, and an ion-pairing acid such as trifluoroacetic acid. The chemistry carries over from HPLC to UPLC. What changes is the hardware and the column geometry.
The core differences
Two specifications define the divide: the pressure the system can withstand and the particle size in the column. According to the CASRAI comparison, conventional HPLC uses 3–5 µm particles at up to about 400 bar, while UPLC and UHPLC use sub-2 µm particles at pressures from around 1,000 bar upwards, with some systems rated higher.
Smaller particles shorten the distance a molecule has to diffuse, which tightens peaks. But packing a column with tiny particles creates high backpressure, so the pump, the seals and the flow path all have to be built for it.
| Feature | Conventional HPLC | UPLC / UHPLC |
|---|---|---|
| Typical pressure limit | Up to about 400 bar (around 6,000 psi) | About 1,000 bar and above, up to 1,500 bar on some systems |
| Column particle size | 3–5 µm | Under 2 µm |
| Run time | Longer, often tens of minutes for a peptide gradient | Often much shorter on a comparable separation |
| Peak capacity and resolution | Good | Higher |
| Solvent use per run | Higher | Lower |
| System dispersion | Larger tubing and flow-cell volumes | Minimised, to protect narrow peaks |
| Purchase and running cost | Lower | Higher |
| Fit | Routine QC, validated methods | R&D, high throughput, complex samples |
The pressure figures come from the CASRAI buying guide and the Shimadzu knowledge base. Exact limits vary by instrument, so check the specification of the system you actually use.
UPLC or UHPLC?
The two terms describe the same class of technique. UPLC is the Waters trademark, and UHPLC is the generic term other manufacturers use. CASRAI sets out the distinction. In a methods section, write "UHPLC" unless you are using a Waters instrument and want to name it.
Why the difference matters for peptides
Peptides are a demanding test for any column. Synthetic peptides come with truncated sequences, deletion products, incompletely deprotected species and oxidised or racemised variants. Many of these differ from the target by a single residue and elute right next to it. A purity figure is only as honest as the method's ability to pull those neighbours apart.
This is where UPLC earns its keep. A Waters application note on peptide reversed-phase methods compared platforms using the same gradient and column conditions. It reported peak capacity rising from 118 on the HPLC system to 196 on the UPLC system, and resolution of a critical peak pair improving from 1.7 to 3.1. That is one vendor's study of one set of conditions, so treat the numbers as an illustration rather than a rule. The direction is consistent with the theory, though: lower extra-column band broadening gives sharper peaks and better separation of near neighbours.
A resolution of 1.7 between a main peak and an impurity is borderline. Integrating those two peaks reliably is difficult, and a small shoulder can be absorbed into the main peak, which inflates the apparent purity. At 3.1 the peaks are cleanly separated and each area is trustworthy.
The van Deemter argument in one paragraph
The van Deemter equation relates column efficiency to flow rate and describes why smaller particles help: shorter diffusion paths mean less band broadening, and the efficiency holds up at higher flow rates. That is why UPLC can be both faster and sharper. The PMC paper on gradient retention factors in peptide RP-HPLC applies the van Deemter model to compare monolithic, fully packed and core–shell stationary phases for synthetic peptide mixtures, which is a useful read if you want to see the theory worked on real peptides.
What it costs to run each
The purchase price is only the start. The Shimadzu knowledge base points out that UHPLC costs more across the board:
- Instrument: high-pressure pumps and low-dispersion flow paths cost more to build.
- Columns: sub-2 µm columns are dearer and are more sensitive to blockage.
- Solvents: high-purity, LC-MS grade solvents are needed, and mobile phases and samples should be filtered to 0.2 µm or finer.
- Maintenance: running at extreme pressure puts more stress on seals and pump components.
The same source notes that failing to filter samples is a common pitfall. It quickly blocks the column inlet frit and triggers pressure alarms, which halts a high-throughput workflow. A fair comparison sets those costs against the time saved. If you run 10 samples a week, the saved minutes may never repay the upgrade. If you run 200, they will.
Which one should you use?
The best choice follows the application, not the label. The Shimadzu guidance summarises it well: conventional HPLC remains the rugged, cost-effective standard for routine QC of validated methods, while UHPLC suits R&D, high throughput and the highest resolution of complex biomolecules such as synthetic peptides.
A practical way to decide:
- You release batches against a validated pharmacopoeial method. Stay on HPLC unless there is a clear reason to move, because the method is already proven on that platform.
- You develop methods or characterise impurity profiles. Use UHPLC. The extra resolution shows impurities that a coarser separation would hide.
- You run many samples a day. UHPLC's shorter cycle time and lower solvent use usually pay back.
- You need both. Many labs choose a convertible or hybrid system that can run either type of method.
- You are connecting to mass spectrometry. Narrow, sharp UHPLC peaks suit MS detection well, and LC-MS grade solvents are needed anyway.
Moving a method between HPLC and UPLC
Transferring a method is not as simple as buying a smaller column. Two issues catch people out.
Extra-column dispersion
According to Shimadzu, a sub-2 µm column fitted to a standard HPLC instrument can lose its resolution gain, because the instrument's tubing and flow-cell volumes broaden the peaks again. Some labs work around this with a wider-bore column or optimised flow-cell components, but the full benefit needs a system designed for it.
Gradient scaling and dwell volume
For peptides, scaling the flow rate and injection volume alone is not enough. A 2026 paper on peptide purification and analytical transferability stresses the gradient retention factor and the effect of system-dependent dwell volume, which can change the elution profile drastically. Gradient calculators and standard correction equations help you avoid redeveloping the method on each instrument. A Waters application note on synthetic peptide impurity analysis shows a worked transfer between UPLC and HPLC using the peptide eledoisin.
Pharmacopoeial methods
If you follow compendial methods, the rules allow some adjustment without full revalidation. The British Pharmacopoeia supplementary chapter on analytical quality by design discusses the harmonised chapter that permits column length to particle size ratios to vary within set limits, provided system suitability criteria such as resolution and peak symmetry are still met. Changes outside the permitted ranges generally call for formal revalidation. Read the current text of your pharmacopoeia and confirm with your quality unit before you change a validated method.
Reading a peptide purity figure
A claim of 99% purity by HPLC is a statement about a particular chromatogram. Several things shape that number:
- Detection wavelength. Peptides are usually monitored at 214 or 220 nm, where the peptide bond absorbs. Impurities without a chromophore at that wavelength do not appear.
- Gradient steepness. A shallow gradient separates close neighbours. A steep one can merge them into the main peak.
- Column and platform. The same sample can look purer on a lower-resolution system, because co-eluting impurities are counted as part of the main peak.
- Peak integration. Baseline placement and shoulder handling change the area percentage.
- What purity does not tell you. Area percentage by UV is not the same as peptide content. Water, counter-ions such as TFA and residual salts can make up a sizeable share of the lyophilised mass. Identity is normally confirmed separately, for example by mass spectrometry.
That is why a single number on a product page is only the starting point. Ask for the Certificate of Analysis and check that it names the method, shows the chromatogram and reports a mass confirmation.
Our perspective on HPLC, UPLC and purity
We supply research peptides, and our headline specification is 99%+ HPLC purity. We think that figure should invite scrutiny, not end it. A purity percentage is a measurement, and measurements have methods behind them.
Our view is simple. Researchers deserve to see how a number was produced. That is why we support our products with Certificates of Analysis and why we describe our quality controls and verification processes openly. If your own work depends on resolving closely related impurities, such as in a stability study or an impurity profile, the platform and gradient matter, and you should compare the CoA against what your own method can see.
We also believe the choice between HPLC and UPLC is not a contest. Validated QC belongs on stable, well-understood methods. Method development and impurity hunting belong on the highest resolution you can access. Good science uses both for what each does best.
All our peptides are supplied strictly for laboratory and scientific research. They are not for human or veterinary consumption, and our research use only page sets out what that means for buyers.
— Neil
Sourcing peptides for your analytical work
If you are building or validating a purity method, you need a reference material whose documentation you can trust. BioForgeUK supplies research peptides at 99%+ HPLC purity, with Certificates of Analysis and a secure checkout, to scientists, institutions and laboratories. Browse the range at bioforgeuk.co.uk and check the CoA for the batch you are buying against your own method.
FAQ
Is UPLC the same as UHPLC?
In practice, yes. UPLC is a trademark of Waters, and UHPLC is the generic term used across the industry for sub-2 µm, high-pressure liquid chromatography. Individual instruments differ in their pressure ratings and design, so compare specifications rather than names.
Is UPLC always better than HPLC?
No. UPLC gives faster runs and higher resolution, but it costs more to buy and run and demands cleaner solvents and samples. For a validated routine method, HPLC is often the more sensible and economical choice.
Can I run a UPLC method on an HPLC system?
Sometimes, but not by simply swapping columns. You usually need to adjust column dimensions, flow rate and gradient, and allow for dwell volume and extra-column dispersion. Pharmacopoeial methods may permit limited changes without full revalidation, so check the current chapter first.
Why does the analytical platform matter for peptide purity?
A lower-resolution method can merge impurities into the main peak and make a sample look purer than it is. Higher-resolution UPLC can separate closely eluting impurities, so the same material may show a more detailed profile. Always read the method on the CoA alongside the percentage.
Is HPLC the same as electrophoresis?
No. HPLC separates compounds by their interaction with a packed column and a flowing liquid. Electrophoresis separates charged molecules by their movement in an electric field. They can complement each other, but they are different techniques.
Sources
- HPLC vs UPLC vs UHPLC: Buying Guide, CASRAI
- HPLC vs UHPLC, Shimadzu knowledge base
- HPLC vs UPLC: What's the Difference? Chromatography Today
- HPLC, UHPLC and UPLC system performance for a peptide reversed-phase method, Waters
- Method development and transfer of synthetic peptide impurity analysis, Waters
- Gradient retention factor concept applied to peptide analysis by RP-HPLC, PMC
- Improvement of analysis and transferability in peptide purification, PMC
- Application of Analytical Quality by Design to Pharmacopoeial Methods, British Pharmacopoeia